If China is the newly settled prairieland for Aussie milk companies, India is the last frontier — and it’s one that Wattle Health says it has cracked.

The dairy stock (ASX:WHA) has grown fat on its trade with China and now says it has signed a 12-month baby food supply deal in India.

The arrangement is with Vasudevan and Sons Exim Private (VSEP) following a trial order in January.

VSEP is to buy a minimum of $1.5 million of products over the next 12 months, selling into one state at first.

Last year Wattle made $928,426 in sales.

“This agreement opens the door for Wattle to compete in one of the world’s fastest growing economies and most populated countries where almost half the population is under the age of 25,” the company told investors.

Stockhead is seeking comment from Wattle Health.

The stock rose from $1.20 to $1.25 in early Monday trade before closing down slightly at $1.19.